![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,3,5-trinitro-1,3,5-triazinane | decreases expression | ISO | RGD:1625892 | 6480464 | cyclonite results in decreased expression of MIR181D mRNA | CTD | PMID:19270793 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of MIR181D mRNA | CTD | PMID:30328349 | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of MIR181D mRNA | CTD | PMID:18941112 | arsenous acid | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of MIR181D mRNA | CTD | PMID:22072212 | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzoapyrene results in decreased methylation of MIR181D promoter | CTD | PMID:27901495 | Benzo[k]fluoranthene | increases expression | EXP | | 6480464 | benzokfluoranthene results in increased expression of MIR181D mRNA | CTD | PMID:23993976 | bleomycin A2 | decreases expression | ISO | RGD:2325361 | 6480464 | Bleomycin results in decreased expression of MIR181D mRNA | CTD | PMID:25933445 | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of MIR181D mRNA | CTD | PMID:27510461 | dexamethasone | decreases expression | ISO | RGD:1625892 | 6480464 | Dexamethasone results in decreased expression of MIR181D mRNA | CTD | PMID:22110677 | diarsenic trioxide | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of MIR181D mRNA | CTD | PMID:22072212 | endosulfan | decreases expression | ISO | RGD:2325361 | 6480464 | Endosulfan results in decreased expression of MIR181D mRNA | CTD | PMID:31464424 | formaldehyde | decreases expression | EXP | | 6480464 | Formaldehyde results in decreased expression of MIR181D mRNA | CTD | PMID:21147603 | hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of MIR181D mRNA | CTD | PMID:26339600 | lipopolysaccharide | decreases expression | ISO | RGD:1625892 | 6480464 | Lipopolysaccharides results in decreased expression of MIR181D mRNA | CTD | PMID:22110677 | paracetamol | decreases expression | ISO | RGD:2325361 | 6480464 | Acetaminophen results in decreased expression of MIR181D mRNA | CTD | PMID:27397436 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of MIR181D mRNA | CTD | PMID:29067470 | progesterone | increases expression | EXP | | 6480464 | Progesterone results in increased expression of MIR181D mRNA | CTD | PMID:22950660 | progesterone | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of MIR181D mRNA | CTD | PMID:30328349 | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of MIR181D mRNA | CTD | PMID:24431212, PMID:29207610 | sodium fluoride | increases expression | ISO | RGD:1625892 | 6480464 | Sodium Fluoride results in increased expression of MIR181D mRNA | CTD | PMID:29127033 | tetraphene | increases expression | EXP | | 6480464 | benzaanthracene results in increased expression of MIR181D mRNA | CTD | PMID:23993976 | titanium dioxide | increases expression | ISO | RGD:1625892 | 6480464 | titanium dioxide results in increased expression of MIR181D mRNA | CTD | PMID:29247641 | |